Cassava Sciences Inc (SAVA)
26.14
+0.96
(+3.81%)
USD |
NASDAQ |
Nov 14, 16:00
26.09
-0.05
(-0.19%)
After-Hours: 20:00
Cassava Sciences Gross Profit (Annual)
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2009 | 20.56M |
| December 31, 2008 | 63.72M |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 |
| Date | Value |
|---|---|
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | 6.158M |
| December 31, 1999 | 1.539M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Bristol-Myers Squibb Co | 34.31B |
| Seelos Therapeutics Inc | -- |
| EyePoint Pharmaceuticals Inc | 41.39M |
| PTC Therapeutics Inc | 872.34M |
| Adverum Biotechnologies Inc | -- |